Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-05-18

FDA Approved: EPINEPHRINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for epinephrine from Amneal Pharmaceuticals of New York LLC, indicating a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

SUPPL AP for EPINEPHRINE (EPINEPHRINE)